Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    "Retroperitoneal fibrosis"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Unknown  Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
Conditions: Idiopathic Retroperitoneal Fibrosis;   Perianeurysmal Retroperitoneal Fibrosis;   Chronic Periaortitis
Interventions: Drug: Methotrexate+Prednisone;   Drug: Prednisone
2 Unknown  Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
Condition: Retroperitoneal Fibrosis
Interventions: Drug: Tamoxifen;   Drug: Prednisone
3 Completed Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Conditions: Retroperitoneal Fibrosis;   Autoimmune Pancreatitis;   Sialadenitis;   Pseudotumor
Intervention: Drug: Rituximab
4 Recruiting Treatment of IgG4-Related Disease With Revlimid and Rituximab
Conditions: Immunoglobulin G Subclass 4 Related Disease;   IgG4-related Disease;   Autoimmune Pancreatitis;   IgG4-related Sclerosing Cholangitis;   Retroperitoneal Fibrosis
Interventions: Drug: Rituximab;   Drug: Lenalidomide
5 Recruiting Leflunomide for Maintenance of Remission in IgG4 Related Disease
Condition: Immunoglobulin G4 Related Sclerosing Disease
Interventions: Drug: Prednisone;   Drug: Leflunomide

Indicates status has not been verified in more than two years